Searched for
DR LAL PATH LABS SHARE PRICE
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growthLaurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by r...27 Jul, 2026, 11.03 AM IST- US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...27 Jul, 2026, 06.44 AM IST
- Two Trades for Today: A diagnostics major for a 6% rise, a large-cap financial service stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...26 Jul, 2026, 07.37 PM IST
- Ahead of Market: 10 things that will decide stock market action on MondayIndian equities extended losses for a fifth straight session, pressured by elevated oil prices and persistent FII outflows. Despite intrada...26 Jul, 2026, 05.03 PM IST
- Unexpected gainer of trouble in the Gulf? 13 stocks from backend of the EV shift, with upside potential of up to 33%Most investors seeking exposure to the EV shift choose the obvious: A pure EV company; a scooter or car maker. They are the face of the tra...26 Jul, 2026, 08.18 AM IST
- Rs 30,000 rent for a cramped Mumbai flat vs free 2 BHK: Doctor reveals why she left the city for a village lifeDr Garima Chauhan, an anesthesiologist, shared why she left Mumbai for a small town despite being a lifelong Mumbaikar. She compared her ex...25 Jul, 2026, 10.23 AM IST
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...23 Jul, 2026, 06.56 PM IST
- Buy, Sell or Hold? Goldman Sachs maintains a buy on Eternal; Citi recommends sell rating on Dr Reddy’s Laboratories post Q1 resultsGoldman Sachs and Citi have issued fresh post-Q1 calls on three stocks. Goldman stays bullish on Eternal (Buy, target Rs 345, 21% upside) d...23 Jul, 2026, 10.45 AM IST
- Dr Reddy’s shares crack 9% after weak Q1; these 3 brokerages slash their target pricesDr Reddy’s shares plunged 9% on Thursday after the drugmaker reported a weak Q1 FY27 performance, with net profit tumbling 69% year-on-year...23 Jul, 2026, 10.02 AM IST
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...22 Jul, 2026, 11.27 AM IST
- Triveni Engineering shares adjust 38.5% as stock turns ex-demerger. What lies ahead for 95,000 shareholdersTriveni Engineering shares appeared to fall sharply after trading ex-demerger, but the decline reflected a technical price adjustment follo...22 Jul, 2026, 10.39 AM IST
- ICMR licenses cancer, vaccine technologies to Emcure, Biological EThe Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment an...22 Jul, 2026, 01.12 AM IST
- Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...21 Jul, 2026, 02.58 PM IST
- MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusionsMSCI’s August India Standard Index review could trigger major passive inflows, with Eternal expected to attract the highest at $648 million...21 Jul, 2026, 11.53 AM IST
- China's Kimi K3 emerges as a low-cost rival to Anthropic's Fable 5China's Kimi K3 AI model is now challenging premium frontier models with its performance. It joins Meta's Muse Spark and Google's Antigravi...19 Jul, 2026, 09.59 PM IST
- For investors with an over 2-year perspective: 5 mid- and small-cap stocks with an upside potential of up to 26%This is a market to be selective in, not brave in. The safer way to play a turn in the market is to stay with businesses whose demand does ...13 Jul, 2026, 12.15 PM IST
- Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?Dr Reddy's Laboratories shares extended their decline after the company delayed commercial supplies of its semaglutide product due to a qua...10 Jul, 2026, 12.36 PM IST
Load More
